- Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. British journal of haematology. 2017 Academic Article GET IT
- High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Journal of hematology & oncology. 2015 Academic Article GET IT
Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.
Times cited: 11
Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia.
Times cited: 3